6 results on '"Ali S. Arbab"'
Search Results
2. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
- Author
-
Raziye Piranlioglu, EunMi Lee, Maria Ouzounova, Roni J. Bollag, Alicia H. Vinyard, Ali S. Arbab, Daniela Marasco, Mustafa Guzel, John K. Cowell, Muthushamy Thangaraju, Ahmed Chadli, Khaled A. Hassan, Max S. Wicha, Esteban Celis, and Hasan Korkaya
- Subjects
Science - Abstract
Dissemination of tumor cells from the primary site is an early event. Here, the authors show that the early disseminated tumor cells are actively cleared by the host cytotoxic T lymphocytes induced by the primary tumor and that infiltration of granulocytic myeloid-derived suppressor cells counteracts such immune protection and allow metastasis development.
- Published
- 2019
- Full Text
- View/download PDF
3. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
- Author
-
Maria Ouzounova, Eunmi Lee, Raziye Piranlioglu, Abdeljabar El Andaloussi, Ravindra Kolhe, Mehmet F. Demirci, Daniela Marasco, Iskander Asm, Ahmed Chadli, Khaled A. Hassan, Muthusamy Thangaraju, Gang Zhou, Ali S. Arbab, John K. Cowell, and Hasan Korkaya
- Subjects
Science - Abstract
Myeloid-derived suppressive cells (MDSCs) promote metastasis. Here, the authors show that the monocytic MDSCs subset promotes epithelial to mesenchymal transition at the primary site while the granulocytic subset promotes the reverse transition at the metastatic site enabling dynamic tumour cells plasticity.
- Published
- 2017
- Full Text
- View/download PDF
4. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
- Author
-
Lei Huang, Ningchun Xu, Paulo C. Rodriguez, Madison Canning, Gang Guo, Yan Cui, Ali S. Arbab, Chang Sheng Chang, Bhagelu R. Achyut, Miao Yu, Huidong Shi, David H. Munn, Libin Deng, Roni J. Bollag, and Andrew L. Mellor
- Subjects
0301 basic medicine ,Science ,Population ,General Physics and Astronomy ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,NT5E ,0302 clinical medicine ,Immune system ,Downregulation and upregulation ,Medicine ,Receptor ,education ,lcsh:Science ,Tumor microenvironment ,education.field_of_study ,Multidisciplinary ,business.industry ,fungi ,food and beverages ,General Chemistry ,Immune checkpoint ,3. Good health ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer research ,Cancer-Associated Fibroblasts ,lcsh:Q ,business - Abstract
CD73, an ecto-5′-nucleotidase (NT5E), serves as an immune checkpoint by generating adenosine (ADO), which suppresses immune activation through the A2A receptor. Elevated CD73 levels in tumor tissues correlate with poor clinical outcomes. However, the crucial source of CD73 activity within the tumor microenvironment remains unspecified. Here, we demonstrate that cancer-associated fibroblasts (CAFs) constitute the prominent CD73hi population in human colorectal cancers (CRCs) and two CD73− murine tumor models, including a modified CRC. Clinically, high CAF abundancy in CRC tissues correlates strongly with elevated CD73 activity and poor prognosis. Mechanistically, CAF-CD73 expression is enhanced via an ADO-A2B receptor-mediated feedforward circuit triggered by tumor cell death, which enforces the CD73-checkpoint. Simultaneous inhibition of A2A and A2B pathways with CD73-neutralization synergistically enhances antitumor immunity in CAF-rich tumors. Therefore, the strategic and effective targeting of both the A2B-mediated ADO-CAF-CD73 feedforward circuit and A2A-mediated immune suppression is crucial for improving therapeutic outcomes.
- Published
- 2020
5. CD73 on cancer-associated fibroblasts enhanced by the A
- Author
-
Miao, Yu, Gang, Guo, Lei, Huang, Libin, Deng, Chang-Sheng, Chang, Bhagelu R, Achyut, Madison, Canning, Ningchun, Xu, Ali S, Arbab, Roni J, Bollag, Paulo C, Rodriguez, Andrew L, Mellor, Huidong, Shi, David H, Munn, and Yan, Cui
- Subjects
Cancer microenvironment ,Adenosine ,Drug Synergism ,Hematopoietic Stem Cells ,Receptor, Adenosine A2B ,Models, Biological ,Article ,Adenosine A2 Receptor Antagonists ,Up-Regulation ,Mice, Inbred C57BL ,Lymphocytes, Tumor-Infiltrating ,Treatment Outcome ,Cancer-Associated Fibroblasts ,Neutralization Tests ,Cell Line, Tumor ,Disease Progression ,Tumor Microenvironment ,Animals ,Humans ,Immunotherapy ,Colorectal Neoplasms ,Transcriptome ,Cancer models ,5'-Nucleotidase ,Immunosuppression - Abstract
CD73, an ecto-5′-nucleotidase (NT5E), serves as an immune checkpoint by generating adenosine (ADO), which suppresses immune activation through the A2A receptor. Elevated CD73 levels in tumor tissues correlate with poor clinical outcomes. However, the crucial source of CD73 activity within the tumor microenvironment remains unspecified. Here, we demonstrate that cancer-associated fibroblasts (CAFs) constitute the prominent CD73hi population in human colorectal cancers (CRCs) and two CD73− murine tumor models, including a modified CRC. Clinically, high CAF abundancy in CRC tissues correlates strongly with elevated CD73 activity and poor prognosis. Mechanistically, CAF-CD73 expression is enhanced via an ADO-A2B receptor-mediated feedforward circuit triggered by tumor cell death, which enforces the CD73-checkpoint. Simultaneous inhibition of A2A and A2B pathways with CD73-neutralization synergistically enhances antitumor immunity in CAF-rich tumors. Therefore, the strategic and effective targeting of both the A2B-mediated ADO-CAF-CD73 feedforward circuit and A2A-mediated immune suppression is crucial for improving therapeutic outcomes., Our understanding on how CAFs can be activated to support tumour progression is still limited. Here, the authors demonstrate that adenosine produced in the tumour microenvironment can enhance the expression of CD73 in CAFs ultimately driving CD8 T-Cell suppression and tumour growth.
- Published
- 2018
6. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
- Author
-
John K. Cowell, Khaled A. Hassan, Hasan Korkaya, Maria Ouzounova, Ali S. Arbab, Raziye Piranlioglu, Gang Zhou, Muthusamy Thangaraju, Daniela Marasco, Abdeljabar El Andaloussi, Ahmed Chadli, Iskander Asm, Eunmi Lee, Mehmet F. Demirci, Ravindra Kolhe, Ouzounova, Maria, Lee, Eunmi, Piranlioglu, Raziye, El Andaloussi, Abdeljabar, Kolhe, Ravindra, Demirci, Mehmet F, Marasco, Daniela, Asm, Iskander, Chadli, Ahmed, Hassan, Khaled A, Thangaraju, Muthusamy, Zhou, Gang, Arbab, Ali S, Cowell, John K, Korkaya, Hasan, Augusta University, and University System of Georgia (USG)
- Subjects
0301 basic medicine ,[SDV]Life Sciences [q-bio] ,Science ,Cell ,General Physics and Astronomy ,Biology ,Monocytes ,Article ,General Biochemistry, Genetics and Molecular Biology ,Metastasis ,Transcriptome ,03 medical and health sciences ,Lung metastasis, tumor cell plasticity, SOCS proteins ,Cell Line, Tumor ,Neoplasms ,Cell Plasticity ,medicine ,Animals ,Humans ,Neoplasm Metastasis ,Cells, Cultured ,ComputingMilieux_MISCELLANEOUS ,Cell Proliferation ,Mice, Inbred BALB C ,Multidisciplinary ,Cell growth ,Gene Expression Profiling ,Myeloid-Derived Suppressor Cells ,digestive, oral, and skin physiology ,Mammary Neoplasms, Experimental ,General Chemistry ,Gene signature ,medicine.disease ,Phenotype ,3. Good health ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,Immunology ,Myeloid-derived Suppressor Cell ,Cancer research ,Female ,Granulocytes - Abstract
It is widely accepted that dynamic and reversible tumour cell plasticity is required for metastasis, however, in vivo steps and molecular mechanisms are poorly elucidated. We demonstrate here that monocytic (mMDSC) and granulocytic (gMDSC) subsets of myeloid-derived suppressor cells infiltrate in the primary tumour and distant organs with different time kinetics and regulate spatiotemporal tumour plasticity. Using co-culture experiments and mouse transcriptome analyses in syngeneic mouse models, we provide evidence that tumour-infiltrated mMDSCs facilitate tumour cell dissemination from the primary site by inducing EMT/CSC phenotype. In contrast, pulmonary gMDSC infiltrates support the metastatic growth by reverting EMT/CSC phenotype and promoting tumour cell proliferation. Furthermore, lung-derived gMDSCs isolated from tumour-bearing animals enhance metastatic growth of already disseminated tumour cells. MDSC-induced ‘metastatic gene signature' derived from murine syngeneic model predicts poor patient survival in the majority of human solid tumours. Thus spatiotemporal MDSC infiltration may have clinical implications in tumour progression., Myeloid-derived suppressive cells (MDSCs) promote metastasis. Here, the authors show that the monocytic MDSCs subset promotes epithelial to mesenchymal transition at the primary site while the granulocytic subset promotes the reverse transition at the metastatic site enabling dynamic tumour cells plasticity.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.